Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 14
Submit an article Journal homepage
277
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Successful combination treatment with azacitidine and venetoclax for a patient with acute myeloid leukemia undergoing hemodialysis

Taro Edahiroa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
,
Hiroshi Ureshinoa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, JapanCorrespondence[email protected], [email protected]
ORCID Iconhttps://orcid.org/0000-0002-5034-3699
ORCID Icon,
Ren Chishakia Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
,
Keita Fujinoa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
,
Tatsuji Minoa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
,
Tetsumi Yoshidaa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
,
Noriyasu Fukushimaa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan;b Department of Internal Medicine, Karatsu Red Cross Hospital, Karatsu, Japan
&
Tatsuo Ichinohea Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
 show all
Pages 3511-3512 | Received 29 Jun 2022, Accepted 02 Sep 2022, Published online: 13 Sep 2022
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"Successful combination treatment with azacitidine and venetoclax for a patient with acute myeloid leukemia undergoing hemodialysis." Leukemia & Lymphoma, 63(14), pp. 3511–3512

Acknowledgement

The authors thank Hiroki Yamaguchi (Nihon university, Japan) for gene mutational analysis.

Informed consent

The patient provided informed consent to publish this case report.

Disclosure statement

The Next Generation Development of Genome and Cellular Therapy Program at RIRBM is cooperatively funded by Repertoire Genesis Inc. and Hiroshima University. TI has received research funding from AbbVie Inc. and Nippon Shinyaku Co.. No other authors declare potential conflicts of interest (COI).

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.